| Application no. and date | 10162787.5 (espacenet) (Federated) (European Patent Register), 20041209 | | Patent/reg. no. and date | DK/EP 2218461, 20160420 | | Publication date | 20100818 | | Priority no. and date | US 531639 P, 20031222 | | EP pub. no. and date |
EP 2218461 20100818 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340, US | | Applicant ref. no. | SH/AP/153102 | | Inventor | Bedian, Vahe, Pfizer Global Research & Development
Eastern Point Road
Groton, CT 06340, US,
Cusmano, John, Daniel, Pfizer Global Research & Development
Eastern Point Road
Groton, CT 06340, US,
Gladue, Ronald, Paul, Pfizer Global Research & Development
Eastern Point Road
Groton, CT 06340, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , A61K 31/00 (2006.01) | | Title | CD40-antistofformulering og fremgangsmåder | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
